A randomized, placebo-controlled, double-blinded pilot study of angiotensin 1-7 (TXA-127) for the treatment of severe COVID-19. - Wagener G; Goldklang MP; Gerber A; Elisman K; Eiseman KA; Fonseca LD; D'Armiento JM (Critical care (London, England), 2022)